BioLargo's subsidiary Clyra Medical secures over $1 million in direct investments to finalize the acquisition of the breakthrough stem cell therapy technology SkinDisc
Stock Information for Biolargo Inc
Loading
Please wait while we load your information from QuoteMedia.